Leerink is out with commentary on Allergan (NYSE: AGN) following news that it and Pfizer (NYSE: PFE) are in talks ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Mergers and Acquisitions

Allergen (AGN)/Pfizer (PFE) Deal Creates Mid-Teens Synergies in Year 2 - RBC CapitalOctober 29, 2015 10:40 AM Potential Allergan (AGN), Pfizer (PFE) Tie-Up No Surprise But May Take $400 to Get DoneOctober 29, 2015 9:50 AM Allergan (AGN) Affirms Talks with Pfizer (PFE)October 29, 2015 9:31 AM Pfizer (PFE), Allergan (AGN) in Talks About Blockbuster Deal - WSJOctober 28, 2015 9:34 PM